CG Oncology Q3 EPS $(0.64) Beats $(0.82) Estimate, Sales $1.604M Beat $643.584K Estimate

CG Oncology (NASDAQ:CGON) reported quarterly losses of $(0.64) per share which beat the analyst consensus estimate of $(0.82) by 21.95 percent. This is a 12.28 percent decrease over losses of $(0.57) per share from the same period last year. The company reported quarterly sales of $1.604 million which beat the analyst consensus estimate of $643.584 thousand by 149.23 percent. This is a 3.72 percent decrease over sales of $1.666 million the same period last year.